Diligence briefsIC memo prepPortfolio updates

MindLab turns deal materials, notes, models, and prior decisions into source-backed work your team can review, approve, and reuse.

Source room
Review queue
Approved company record

Investment Workspace

Source room. Review queue. Approved company record.

MindLab gives each deal a working surface: source material on the left, reviewer-controlled output on the right, and a company record that keeps only what the team approves.

Source Material
Pitch deck
Atlas Clinical AI Series B
Market, product, ARR, customer claims
Data room
Financial model v12.xlsx
Revenue bridge and margin assumptions
Meeting notes
Founder call and partner comments
Open questions, objections, next asks
Prior work
Healthcare AI thesis memo
Firm criteria and hard-pass logic
MindLab
Firm Context Engine
Extract claims, figures, and assumptions
Surface conflicts and missing evidence
Route draft work through review
Save only approved context
AI prepares. Humans approve. MindLab remembers.
Reviewable Outputs
Diligence brief
First read your team can verify
Claims, risks, gaps, and follow-up questions prepared with source context.
IC memo sections
Draft language partners can challenge
Market, traction, risk, and recommendation sections tied to review flags.
Company record
Approved judgment that survives the meeting
Reviewer notes, source links, assumptions, and decisions remain reusable.
One company record

Documents, notes, questions, risks, decisions, and approved outputs stay organized around the company.

Evidence under every claim

Important claims stay connected to sources, conflicts, missing information, and reviewer flags.

Reusable approval state

The next memo, meeting, portfolio update, or advisor answer starts from what the firm already approved.

Product Tour

See how a deal becomes a working record.

Use MindLab for the jobs investment teams repeat constantly: first reads, diligence questions, memo sections, meeting prep, portfolio updates, and company records.

Company Record

Start from the company record, not the folder.

MindLab organizes documents, meeting notes, partner comments, risks, open questions, and approved outputs around the company under review.

Source documents
Partner comments
Open questions
Decision history
Company Record
Atlas Clinical AI

Healthcare workflow automation platform under Series B review.

Review active
ARR
$18.4M
+62% YoY
Gross margin
74%
2 sources agree
NRR
128%
Partner review
Record contents
Pitch deck
58 claims linked
approved
Financial model
12 assumptions flagged
review
Founder call notes
9 follow-ups captured
draft
Partner comments
3 objections preserved
internal
Diligence Support

Interrogate claims without losing the source trail.

Claims, conflicts, missing information, and follow-up questions are prepared for human review instead of becoming another answer no one can verify.

Claim extraction
Source citations
Conflict flags
Missing-information markers
Source map
1
CIM.pdf
Revenue bridge
2
Model.xlsx
ARR by segment
3
Call notes
Customer expansion
4
Board deck
Hiring plan
Diligence answer
What would need to be true for Atlas to support a $220M entry valuation?

The case depends on sustaining 55%+ revenue growth while keeping gross margin above 70%12. Current evidence supports the margin claim, but expansion revenue is concentrated in three enterprise accounts3.

Review flag

Board deck and model disagree on 2026 sales hiring. Ask management which plan is current before finalizing the memo.

Suggested follow-up: request cohort-level NRR by customer size and implementation timeline.
IC Memo Prep

Prepare IC sections reviewers can challenge.

Memo language starts from source material, firm criteria, prior notes, and reviewer edits, then returns to the company record after approval.

Memo sections
Reviewer notes
Approved language
Version context
IC memo risk section
Atlas Clinical AI - Investment Review
v0.8 review
Market and product

Atlas sells workflow automation into specialty clinics where manual documentation and prior authorization create measurable administrative load1.

Key risk

The primary diligence issue is whether expansion revenue is durable outside the initial enterprise cohort3.

Reviewer note

Partner asked to compare against the 2024 rejected RPM deal before approval.

Approval state
Source checks
Complete
Partner edits
In review
External sharing
Blocked
Approved language will be saved back to the company record after human review.
Portfolio Monitoring

Turn updates into decisions, not another email thread.

New updates are compared against prior assumptions, risks, questions, and approved records so the team can focus on what changed.

Quarterly changes
Assumption drift
Open risks
Reusable update history
Portfolio monitor
Q2 update prep
Compared against prior record
Revenue
$5.2M MRR
+18% QoQ - Ahead of plan
Implementation
64 days
+11 days - Watch item
Pipeline
$41M
-9% QoQ - Partner question
Meeting brief

The update is positive on revenue but raises a delivery-capacity question. Ask whether implementation delays are customer-specific or structural.

Memory saved
Approved KPI note
Open question
Next board ask
MindLab Difference

A one-off answer helps once. Approved work helps the next team too.

MindLab preserves the source trail, reviewer judgment, approval state, and company context so the next workflow starts from what the firm already trusts.

What Changes

Spend less time assembling the case. More time making the call.

MindLab handles the repeatable work around a deal: organize the source set, expose what needs review, draft the first pass, and keep what the team approves.

Fewer cold starts for every new memo or update
Less manual stitching across folders, calls, and models
A company record that gets stronger after every review

Source Review

Atlas Clinical AI diligence
Partner review active

Inputs

Series B deck

18

18 deal claims linked

Model v12

Flag

Revenue bridge reconciled

Partner notes

4

4 objections preserved

Review Workspace

Draft claim

Expansion depends on reducing clinical onboarding time below 21 days.

Supported

Deck p.14, call note 05

Needs Review

Cohort data requested

Reviewer edits decide what gets saved, what stays draft, and what gets blocked.

Approved Record

Company Record

Partner-approved thesis

Enterprise clinical teams show stronger pull than SMB practices.

Open diligence question

Validate churn assumptions in hospital expansion cohort.

Comparable pattern

Similar buyer-risk pattern seen in rejected RPM review.

The first read starts with evidence

Claims, figures, risks, and missing information are pulled into view before the analyst begins writing.

Contradictions surface earlier

Decks, models, notes, and updates are checked against one another so weak claims are caught before the meeting.

Your firm’s lens follows the work

Criteria, prior decisions, and partner concerns stay attached to the company instead of disappearing into old files.

One source set becomes many outputs

Use the same evidence base for diligence briefs, memo sections, meeting prep, updates, and advisor responses.

The next pass starts ahead

Approved notes, assumptions, objections, and decisions stay in the company record for the next review cycle.

External answers stay controlled

Internal notes, valuation debate, and raw partner comments stay out of external-facing responses unless approved.

Pilot Evidence

Prove the system on one workflow before you expand it.

The first MindLab workflow should produce more than a polished presentation. It should create a source-backed output, reviewer feedback, and a company record your team can reuse.

How many claims were tied back to source material
Which contradictions, weak claims, and missing items were surfaced
Whether reviewers trusted the draft enough to edit instead of restart
What approved context was saved for the next workflow

Pilot Scorecard

Atlas IC memo workflow
Example

42

claims linked to source

6

conflicts surfaced

3

outputs drafted

19

approved record items

Evidence areas

Evidence coverage91%

Deck, model, call notes, and prior memo connected

Reviewer confidence84%

Unsupported claims blocked before memo export

Reuse value76%

Approved assumptions saved for the next review

Pilot decision

Continue

Memo risk section met review standard

Expand

Add portfolio update workflow next

Preserve

Approved assumptions saved to record

Trust Console

Atlas Clinical AI workspace
External boundary active
Knowledge setUseStatus

Internal workspace

Full source room, notes, partner debate

Internal only

Set

Approved records

Saved decisions and reviewer notes

Approval gate

Set

External advisor

Approved facts only

Restricted answer

Set

Unsupported claim

No source or weak evidence

Blocked

Set

Current external response

12 approved facts available. Internal notes, valuation debate, and partner comments blocked.

Trust By Design

The more AI remembers, the more control matters.

MindLab is built for sensitive investment work where teams need source review, approval, separation between internal and external use, and clear rules for what can be used again.

Private by default

Customer materials stay inside the customer workspace and support only the agreed workflows.

Approved before reused

Drafts do not become saved records until humans review the sources, language, and conclusions.

Permissioned answers

Internal work and external advisor responses use different approved knowledge boundaries.

Where MindLab Starts

Start where context leaks fastest.

The best first workflow is the repeated work where documents, notes, reviewer judgment, and prior decisions are expensive to reconstruct.

Discuss implementation fit

Buyer Fit

Where MindLab starts
First workflow selected

Family office

Company records

VC / growth

Diligence support

PE / direct

Memo and risk review

Credit / assets

Monitoring updates

Family offices

Direct deals, fund reviews, portfolio updates, advisor questions

Company records or meeting prep

VC and growth funds

High-volume company review, thesis review, founder meetings

Diligence support or IC memo prep

PE and direct investment

Deeper diligence, risk tracking, operating assumptions

Memo sections or risk review

Private credit and asset managers

Document-heavy review, monitoring, borrower or issuer context

Portfolio monitoring or update prep

Evaluation Questions

Questions buyers ask first

Short answers on workflows, data, implementation, control, and product boundaries.

Next Step

Start with the workflow that costs the most rework.

A private briefing maps the source materials, review process, output standard, and firm context that should survive the next review.

Request a private briefing

No confidential materials required before fit is confirmed.

Private Briefing

Workflow review room
Workflow-first

Decision agenda

01First workflow
02Source readiness
03Reviewer standard
04Pilot decision

Briefing Packet

Workflow candidate

IC memo risk section from real materials

Trust boundary

Internal notes blocked from external output

Pilot evidence

Source flags, reviewer edits, approved records